Individual differences in maternal response to immune challenge predict offspring behavior: Contribution of environmental factors

Behavioural Brain Research

Volumn 220, Issue 1, 2011, Pages 55-64

  Bronson, Stefanie L ^b   Ahlbrand, Rebecca ^a,b   Horn, Paul S ^a,c   Kern, Joseph R ^b   Richtand, Neil M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Body weight; Inflammation; Poly IC; Prenatal immune activation; Psychosocial stress; Schizophrenia

Indexed keywords

AMPHETAMINE; DIZOCILPINE; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BODY WEIGHT DISORDER; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; IMMUNE RESPONSE; IMMUNITY; LOCOMOTION; MALE; MATERNAL AGE; MATERNAL IMMUNE RESPONSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROGENY; RAT; SOCIAL ISOLATION; WEIGHT REDUCTION;

AGE FACTORS; AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTIVIRAL AGENTS; BEHAVIOR, ANIMAL; BODY WEIGHT; CENTRAL NERVOUS SYSTEM STIMULANTS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; INDIVIDUALITY; LOCOMOTION; MALE; POLY I-C; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; WEIGHT GAIN; WEIGHT LOSS;

EID: 79851510670     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.12.040     Document Type: Article

References (83)

1. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 2010, 167:261-280. 10.1176/appi.ajp.2009.09030361.
2. Patterson P.H Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 2009, 204:313-321. 10.1016/j.bbr.2008.12.016.
3. Brown A.S, Schaefer C.A., Wyatt R.J., Goetz R., Begg M.D., Gorman J.M., et al. Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study. Schizophr Bull 2000, 26:287-295.
4. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004, 61:774-780. 10.1001/archpsyc.61.8.774.
5. Buka S.L., Cannon T.D., Torrey E.F., Yolken R.H. Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol Psychiatry 2007, Collaborative Study Group on the Perinatal Origins of Severe Psychiatric Disorders. 10.1016/j.biopsych.2007.09.022.
6. Mednick S.A., Machon R.A., Huttunen M.O., Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988, 45:189-192.
7. O'Callaghan E., Sham P.C., Takei N., Murray G., Glover G., Hare E.H., et al. The relationship of schizophrenic births to 16 infectious diseases. Br J Psychiatry 1994, 165:353-356.
8. Sorensen H.J., Mortensen E.L., Reinisch J.M., Mednick S.A. Association between prenatal exposure to bacterial infection and risk of schizophrenia. Schizophr Bull 2009, 35:631-637. 10.1093/schbul/sbn121.
9. Suvisaari J., Haukka J., Tanskanen A., Hovi T., Lonnqvist J. Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am J Psychiatry 1999, 156:1100-1102.
10. Watson C.G., Kucala T., Tilleskjor C., Jacobs L. Schizophrenic birth seasonality in relation to the incidence of infectious diseases and temperature extremes. Arch Gen Psychiatry 1984, 41:85-90.
11. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007, 27:10695-10702. 10.1523/jneurosci.2178.07.2007.
12. Ellman L.M., Deicken R.F., Vinogradov S., Kremen W.S., Poole J.H., Kern D.M., et al. Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr Res 2010, 10.1016/j.schres.2010.05.014.
13. Diaz R., Ogren S.O., Blum M., Fuxe K. Prenatal corticosterone increases spontaneous and d-amphetamine induced locomotor activity and brain dopamine metabolism in prepubertal male and female rats. Neuroscience 1995, 66:467-473.
14. Mesquita A.R., Wegerich Y., Patchev A.V., Oliveira M., Leao P., Sousa N., et al. Glucocorticoids and neuro- and behavioural development. Semin Fetal Neonatal Med 2009, 14:130-135. 10.1016/j.siny.2008.11.002.
15. Owen D., Andrews M.H., Matthews S.G. Maternal adversity, glucocorticoids and programming of neuroendocrine function and behaviour. Neurosci Biobehav Rev 2005, 29:209-226. 10.1016/j.neubiorev.2004.10.004.
16. Breen J.G., Claggett T.W., Kimmel G.L., Kimmel C.A. Heat shock during rat embryo development in vitro results in decreased mitosis and abundant cell death. Reprod Toxicol 1999, 13:31-39.
17. Edwards M.J. Hyperthermia in utero due to maternal influenza is an environmental risk factor for schizophrenia. Congenit Anom (Kyoto) 2007, 47:84-89. 10.1111/j.1741-4520.2007.00151.x.
18. Upfold J.B., Smith M.S., Edwards M.J. Quantitative study of the effects of maternal hyperthermia on cell death and proliferation in the guinea pig brain on day 21 of pregnancy. Teratology 1989, 39:173-179. 10.1002/tera.1420390209.
19. Shen Q., Li Z.Q., Sun Y., Wang T., Wan C.L., Li X.W., et al. The role of pro-inflammatory factors in mediating the effects on the fetus of prenatal undernutrition: implications for schizophrenia. Schizophr Res 2008, 99:48-55. 10.1016/j.schres.2007.10.010.
20. Susser E.S., Brown A.S., Gorman J.M. Prenatal exposures in schizophrenia 1999, American Psychiatric Press, Washington, DC, 275 pp. 1st ed.
21. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003, 23:297-302.
22. Fatemi S.H., Earle J., Kanodia R., Kist D., Emamian E.S., Patterson P.H., et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 2002, 22:25-33.
23. Ashdown H., Dumont Y., Ng M., Poole S., Boksa P., Luheshi G.N. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry 2006, 11:47-55. 10.1038/sj.mp.4001748.
24. Borrell J., Vela J.M., Arevalo-Martin A., Molina-Holgado E., Guaza C. Prenatal immune challenge disrupts sensorimotor gating in adult rats Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 2002, 26:204-215. 10.1016/S0893-133X(01)00360-8.
25. Fortier M.E., Joober R., Luheshi G.N., Boksa P. Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res 2004, 38:335-345. 10.1016/j.jpsychires.2003.10.001.
26. Fortier M.E., Luheshi G.N., Boksa P. Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav Brain Res 2007, 181:270-277. 10.1016/j.bbr.2007.04.016.
27. Romero E., Guaza C., Castellano B., Borrell J. Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia. Mol Psychiatry 2010, 15:372-383. 10.1038/mp.2008.44.
28. Urakubo A., Jarskog L.F., Lieberman J.A., Gilmore J.H. Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophr Res 2001, 47:27-36.
29. Meyer U., Feldon J., Schedlowski M., Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 2005, 29:913-947. 10.1016/j.neubiorev.2004.10.012.
30. Ozawa K., Hashimoto K., Kishimoto T., Shimizu E., Ishikura H., Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 2006, 59:546-554. 10.1016/j.biopsych.2005.07.031.
31. Zuckerman L., Rehavi M., Nachman R., Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 2003, 28:1778-1789. 10.1038/sj.npp.1300248.
32. Samuelsson A.M., Jennische E., Hansson H.A., Holmang A. Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1345-R1356. 10.1152/ajpregu.00268.2005.
33. Bronson S.L., Richtand N.M. Developmental consequences of prenatal immune activation. Handbook of schizophrenia spectrum disorders 2011, vol. I. Springer. 1st ed.
34. Meyer U., Feldon J., Fatemi S.H. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev 2009, 33:1061-1079. 10.1016/j.neubiorev.2009.05.001.
35. Suh H.S., Brosnan C.F., Lee S.C. Toll-like receptors in CNS viral infections. Curr Top Microbiol Immunol 2009, 336:63-81. 10.1007/978-3-642-00549-7_4.
36. Cunningham C., Campion S., Teeling J., Felton L., Perry V.H. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav Immun 2007, 21:490-502. 10.1016/j.bbi.2006.12.007.
37. Fortier M.E., Kent S., Ashdown H., Poole S., Boksa P., Luheshi G.N. The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 2004, 287:R759-R766. 10.1152/ajpregu.00293.2004.
38. Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun 2010, 24:881-897. 10.1016/j.bbi.2010.03.005.
39. Gilmore J.H., Jarskog L.F., Vadlamudi S. Maternal poly I:C exposure during pregnancy regulates TNF alpha BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat. J Neuroimmunol 2005, 159:106-112. 10.1016/j.jneuroim.2004.10.008.
40. Pritchard L.M., Logue A.D., Hayes S., Welge J.A., Xu M., Zhang J., et al. ichtand NM 7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment. Neuropsychopharmacology 2003, 28:100-107. 10.1038/sj.npp.1300018.
41. McCormick C.M., Mathews I.Z., Thomas C., Waters P. Investigations of HPA function and the enduring consequences of stressors in adolescence in animal models. Brain Cogn 2010, 72:73-85. 10.1016/j.bandc.2009.06.003.
42. Andine P., Widermark N., Axelsson R., Nyberg G., Olofsson U., Martensson E., et al. Characterization of MK-801-induced behavior as a putative rat model of psychosis. J Pharmacol Exp Ther 1999, 290:1393-1408.
43. Devaud L.L. Effects of ethanol or rimcazole on dizocilpine maleate-induced behaviors in male and female rats. Alcohol 2003, 29:69-81.
44. Al-Amin H.A., Shannon Weickert C., Weinberger D.R., Lipska B.K. Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus. Biol Psychiatry 2001, 49:528-539.
45. Segal D.S., Kuczenski R. Behavioral pharmacology of amphetamine. Anonymous amphetamine and its analogues: pharmacology, toxicology, and abuse 1994, Academic Press, Orlando, FL, p. 115.
46. Welge J.A., Richtand N.M. Regression modeling of rodent locomotion data. Behav Brain Res 2002, 128:61-69.
47. Gandhi R., Hayley S., Gibb J., Merali Z., Anisman H. Influence of poly I:C on sickness behaviors, plasma cytokines, corticosterone and central monoamine activity: moderation by social stressors. Brain Behav Immun 2007, 21:477-489. 10.1016/j.bbi.2006.12.005.
48. Brown K.J., Grunberg N.E. Effects of housing on male and female rats: crowding stresses male but calm females. Physiol Behav 1995, 58:1085-1089.
49. Serra M., Pisu M.G., Floris I., Biggio G. Social isolation-induced changes in the hypothalamic-pituitary-adrenal axis in the rat. Stress 2005, 8:259-264. 10.1080/10253890500495244.
50. Sharp J., Zammit T., Azar T., Lawson D. Stress-like responses to common procedures in individually and group-housed female rats. Contemp Top Lab Anim Sci 2003, 42:9-18.
51. Weiss I.C., Pryce C.R., Jongen-Relo A.L., Nanz-Bahr N.I., Feldon J. Effect of social isolation on stress-related behavioural and neuroendocrine state in the rat. Behav Brain Res 2004, 152:279-295. 10.1016/j.bbr.2003.10.015.
52. Wolff A.R., Bilkey D.K. The maternal immune activation (MIA) model of schizophrenia produces pre-pulse inhibition (PPI) deficits in both juvenile and adult rats but these effects are not associated with maternal weight loss. Behav Brain Res 2010, 213:323-327. 10.1016/j.bbr.2010.05.008.
53. Cooper K.E., Blahser S., Malkinson T.J., Merker G., Roth J., Zeisberger E. Changes in body temperature and vasopressin content of brain neurons, in pregnant and non-pregnant guinea pigs, during fevers produced by Poly I:Poly C. Pflugers Arch 1988, 412:292-296.
54. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 2001, 933:222-234.
55. Hart B.L. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 1988, 12:123-137.
56. Buchanan J.B., Johnson R.W. Regulation of food intake by inflammatory cytokines in the brain. Neuroendocrinology 2007, 86:183-190. 10.1159/000108280.
57. Kent S., Bret-Dibat J.L., Kelley K.W., Dantzer R. Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci Biobehav Rev 1996, 20:171-175.
58. Plata-Salaman C.R., Sonti G., Borkoski J.P., Wilson C.D., French-Mullen J.M. Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiol Behav 1996, 60:867-875.
59. Allison D.B., Newcomer J.W., Dunn A.L., Blumenthal J.A., Fabricatore A.N., Daumit G.L., et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med 2009, 36:341-350. 10.1016/j.amepre.2008.11.020.
60. Fagiolini A., Goracci A. The effects of undertreated chronic medical illnesses in patients with severe mental disorders. J Clin Psychiatry 2009, 70(Suppl. 3):22-29. 10.4088/jcp.7075su1c.04.
61. Newcomer J.W., Metabolic syndrome, mental illness. Am J Manag Care 2007, 13:S170-S177.
62. Meyer U., Nyffeler M., Yee B.K., Knuesel I., Feldon J. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 2008, 22:469-486. 10.1016/j.bbi.2007.09.012.
63. Meyer U., Nyffeler M., Schwendener S., Knuesel I., Yee B.K., Feldon J. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 2008, 33:441-456. 10.1038/sj.npp.1301413.
64. Zuckerman L., Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 2005, 39:311-323. 10.1016/j.jpsychires.2004.08.008.
65. Coyle J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006, 26:365-384. 10.1007/s10571-006-9062-8.
66. Javitt D.C. Glutamate and schizophrenia: phencyclidine N-methyl-d-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol 2007, 78:69-108. 10.1016/S0074-7742(06)78003-5.
67. Lisman J.E., Coyle J.T., Green R.W., Javitt D.C., Benes F.M., Heckers S., et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 2008, 31:234-242. 10.1016/j.tins.2008.02.005.
68. Druhan J.P., Rajabi H., Stewart J. MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens. Synapse 1996, 24:135-146. 10.1002/(SICI)1098-2396(199610)24:2<135::AID-SYN5>3.0.CO;2-G.
69. Marcus M.M., Mathe J.M., Nomikos G.G., Svensson T.H. Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens. Neuropharmacology 2001, 40:482-490.
70. Roenker NL, Ahlbrand R, Richtand NM, Gudelsky GA. Effect of risperidone, L-NAME or prenatal immune activation on the MK-801-induced increase in extracellular glutamate in the prefrontal cortex. 2009 Neuroscience Meeting Planner. Chicago, IL: Society for Neuroscience, 2009. Online., 2009:Program Number 443.23/R9.
71. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991, 148:1301-1308.
72. Krystal J.H., D'Souza D.C., Petrakis I.L., Belger A., Berman R.M., Charney D.S., et al. NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv Rev Psychiatry 1999, 7:125-143.
73. Bakos J., Duncko R., Makatsori A., Pirnik Z., Kiss A., Jezova D. Prenatal immune challenge affects growth, behavior, and brain dopamine in offspring. Ann N Y Acad Sci 2004, 1018:281-287. 10.1196/annals.1296.033.
74. Meyer U., Engler A., Weber L., Schedlowski M., Feldon J. Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy. Neuroscience 2008, 154:701-709. 10.1016/j.neuroscience.2008.04.031.
75. Vuillermot S., Weber L., Feldon J., Meyer U. A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci 2010, 30:1270-1287. 10.1523/jneurosci.5408.09.2010.
76. Winter C., Djodari-Irani A., Sohr R., Morgenstern R., Feldon J., Juckel G., et al. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. Int J Neuropsychopharmacol 2009, 12:513-524. 10.1017/S1461145708009206.
77. Segal D.S. Behavioral characterization of d- and l-amphetamine: neurochemical implications. Science 1975, 190:475-477.
78. Heidbreder C., Feldon J. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens. Synapse 1998, 29:310-322. 10.1002/(SICI)1098-2396(199808)29:4<310::AID-SYN3>3.0.CO;2-8.
79. Nelson R.J., Demas G.E. Seasonal changes in immune function. Q Rev Biol 1996, 71:511-548.
80. Brown A.S., Susser E.S. Prenatal nutritional deficiency and risk of adult schizophrenia. Schizophr Bull 2008, 34:1054-1063. 10.1093/schbul/sbn096.
81. Palmer A.A., Printz D.J., Butler P.D., Dulawa S.C., Printz M.P. Prenatal protein deprivation in rats induces changes in prepulse inhibition and NMDA receptor binding. Brain Res 2004, 996:193-201.
82. Palmer A.A., Brown A.S., Keegan D., Siska L.D., Susser E., Rotrosen J., et al. Prenatal protein deprivation alters dopamine-mediated behaviors and dopaminergic and glutamatergic receptor binding. Brain Res 2008, 1237:62-74. 10.1016/j.brainres.2008.07.089.
83. Vucetic Z., Totoki K., Schoch H., Whitaker K.W., Hill-Smith T., Lucki I., et al. Early life protein restriction alters dopamine circuitry. Neuroscience 2010, 168:359-370. 10.1016/j.neuroscience.2010.04.010.